HK1096605A1 - Combinations comprising antimuscarinic agents and beta-adrenergic agonists - Google Patents

Combinations comprising antimuscarinic agents and beta-adrenergic agonists

Info

Publication number
HK1096605A1
HK1096605A1 HK07103580.3A HK07103580A HK1096605A1 HK 1096605 A1 HK1096605 A1 HK 1096605A1 HK 07103580 A HK07103580 A HK 07103580A HK 1096605 A1 HK1096605 A1 HK 1096605A1
Authority
HK
Hong Kong
Prior art keywords
beta
combinations
adrenergic agonists
antimuscarinic agents
anion
Prior art date
Application number
HK07103580.3A
Other languages
English (en)
Inventor
Escardo Jordi Gras
Calvo Jesus Llenas
Hamish Ryder
Diaz Pio Orviz
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200401312A external-priority patent/ES2257152B1/es
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of HK1096605A1 publication Critical patent/HK1096605A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK07103580.3A 2004-05-31 2007-04-03 Combinations comprising antimuscarinic agents and beta-adrenergic agonists HK1096605A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ES200401312A ES2257152B1 (es) 2004-05-31 2004-05-31 Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
EP2005001969 2005-02-24
GB2005000722 2005-02-25
GB2005000740 2005-02-25
PCT/EP2005/005837 WO2005115463A1 (fr) 2004-05-31 2005-05-31 Combinaisons d'agents antimuscariniques et d'agonistes beta-adrenergique

Publications (1)

Publication Number Publication Date
HK1096605A1 true HK1096605A1 (en) 2007-06-08

Family

ID=34968792

Family Applications (1)

Application Number Title Priority Date Filing Date
HK07103580.3A HK1096605A1 (en) 2004-05-31 2007-04-03 Combinations comprising antimuscarinic agents and beta-adrenergic agonists

Country Status (21)

Country Link
US (2) US20110224177A1 (fr)
EP (5) EP2210614A1 (fr)
JP (1) JP2012211183A (fr)
AT (3) ATE454904T1 (fr)
AU (3) AU2005247105B2 (fr)
CA (3) CA2568571C (fr)
CY (1) CY1110829T1 (fr)
DE (3) DE602005022499D1 (fr)
DK (2) DK1905451T3 (fr)
ES (2) ES2336144T3 (fr)
HK (1) HK1096605A1 (fr)
HR (3) HRP20090106T3 (fr)
IL (3) IL179685A (fr)
MX (3) MXPA06013846A (fr)
NZ (3) NZ551670A (fr)
PL (2) PL1905451T3 (fr)
PT (3) PT1905451E (fr)
RS (3) RS51422B (fr)
RU (3) RU2379033C2 (fr)
SI (3) SI1765404T1 (fr)
WO (3) WO2005115464A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2165768B1 (es) 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
WO2006085689A1 (fr) * 2005-02-10 2006-08-17 Oncolys Biopharma, Inc. Agent anticancereux a associer a telomelysin
PE20081788A1 (es) * 2007-02-19 2008-12-18 Cipla Ltd Combinaciones farmaceuticas
EP2080508A1 (fr) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Formulation de poudre sèche comprenant un médicament anticholinérgique
EP2080523A1 (fr) * 2008-01-15 2009-07-22 CHIESI FARMACEUTICI S.p.A. Compositions comprenant un agent anti-muscarinique et un bêta-agoniste longue action
EP2100598A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
EP2100599A1 (fr) 2008-03-13 2009-09-16 Laboratorios Almirall, S.A. Composition à inhaler comprenant aclidinium pour le traitement de l'asthme et de maladies respiratoires obstructives chroniques
GB0811100D0 (en) * 2008-06-17 2008-07-23 Astrazeneca Ab New combination
GB0814728D0 (en) * 2008-08-12 2008-09-17 Argenta Discovery Ltd New combination
WO2010097114A1 (fr) * 2009-02-26 2010-09-02 Glaxo Group Limited Nouvelle combinaison d'agents thérapeutiques
PL2400950T3 (pl) 2009-02-26 2019-12-31 Glaxo Group Limited Preparaty farmaceutyczne zawierające 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzylo)oksy]etoksy}heksylo)amino]-1-hydroksyetylo}-2-(hydroksymetylo)fenol
CA2761845C (fr) 2009-05-14 2015-01-20 Tianjin Hemay Bio-Tech Co., Ltd. Derives de thiophene
GB0921075D0 (en) * 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
EP2510928A1 (fr) 2011-04-15 2012-10-17 Almirall, S.A. Aclidinium pour l'amélioration du sommeil des patients avec des maldadies respiratoires
BR112014025518B1 (pt) 2012-04-13 2022-05-24 Glaxosmithkline Intellectual Property Development Limited Partículas agregadas de umeclidinium, vilanterol e fluticasona, composição em pó, inalador, processo para a preparação de partículas agregadas, e, uso de estearato de magnésio em partículas agregadas
GB201222679D0 (en) 2012-12-17 2013-01-30 Glaxo Group Ltd Pharmaceutical combination products
CA2902403C (fr) 2013-03-15 2021-06-01 Verona Pharma Plc Combinaison d'inhibiteur de phosphodiesterase (pde 3)/d'inhibiteur de phosphodiesterase (pde 4)/antagoniste des recepteurs
GB201308933D0 (en) * 2013-05-17 2013-07-03 Diurnal Ltd Paediatric composition
RU2656154C2 (ru) * 2013-07-05 2018-05-31 Байонир Корпорейшн СВЯЗАННАЯ С РЕСПИРАТОРНЫМ ЗАБОЛЕВАНИЕМ ГЕН-СПЕЦИФИЧЕСКАЯ миРНК, ДВУСПИРАЛЬНАЯ КОНСТРУКЦИЯ ОЛИГО-РНК, СОДЕРЖАЩАЯ миРНК, И СОДЕРЖАЩАЯ ЕЕ КОМПОЗИЦИЯ ДЛЯ ПРЕДУПРЕЖДЕНИЯ ИЛИ ЛЕЧЕНИЯ РЕСПИРАТОРНОГО ЗАБОЛЕВАНИЯ
TW201542207A (zh) * 2013-10-03 2015-11-16 Otsuka Pharma Co Ltd 嚴重氣喘治療劑

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT7920688V0 (it) 1979-02-05 1979-02-05 Chiesi Paolo Parma Inalatore per sostanze medicamentose pulverulente, con combinata funzione di dosatore.
EP0069715B1 (fr) 1981-07-08 1986-11-05 Aktiebolaget Draco Inhalateur de poudre
US4570630A (en) 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
FI69963C (fi) 1984-10-04 1986-09-12 Orion Yhtymae Oy Doseringsanordning
DE3927170A1 (de) 1989-08-17 1991-02-21 Boehringer Ingelheim Kg Inhalator
IT1237118B (it) 1989-10-27 1993-05-18 Miat Spa Inalatore multidose per farmaci in polvere.
US5201308A (en) 1990-02-14 1993-04-13 Newhouse Michael T Powder inhaler
GB9004781D0 (en) 1990-03-02 1990-04-25 Glaxo Group Ltd Device
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
GB9015522D0 (en) 1990-07-13 1990-08-29 Braithwaite Philip W Inhaler
WO1992003175A1 (fr) 1990-08-11 1992-03-05 Fisons Plc Dispositif d'inhalation
DE4027391A1 (de) 1990-08-30 1992-03-12 Boehringer Ingelheim Kg Treibgasfreies inhalationsgeraet
EP0640354B1 (fr) 1990-09-26 2001-12-05 Pharmachemie B.V. Inhalateur pour poudres à tourbillon
GB9026025D0 (en) 1990-11-29 1991-01-16 Boehringer Ingelheim Kg Inhalation device
AU650953B2 (en) 1991-03-21 1994-07-07 Novartis Ag Inhaler
DE4239402A1 (de) 1992-11-24 1994-05-26 Bayer Ag Pulverinhalator
RU2111020C1 (ru) 1992-12-18 1998-05-20 Шеринг Корпорейшн Ингалятор для порошковых лекарств
US5837699A (en) * 1994-01-27 1998-11-17 Schering Corporation Use of mometasone furoate for treating upper airway passage diseases
WO1996032150A1 (fr) 1995-04-14 1996-10-17 Glaxo Wellcome Inc. Inhalateur doseur de salmeterol
PL182198B1 (en) 1995-06-21 2001-11-30 Asta Medica Ag Pharmaceutic powder holding container with integrated measuring device and powdered
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
ES2165768B1 (es) * 1999-07-14 2003-04-01 Almirall Prodesfarma Sa Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
GB0009592D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory combinations
GB0009583D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Respiratory formulations
GB0009606D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Therapeutic combinations
GB0009605D0 (en) 2000-04-18 2000-06-07 Glaxo Group Ltd Medicaments
US7217409B2 (en) * 2000-09-22 2007-05-15 Smithkline Beecham Corporation Alkanoic acid derivatives
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
AU2002210575A1 (en) 2000-10-31 2002-05-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Novel medicament compositions based on anticholinergics and corticosteroids
DE10056104A1 (de) * 2000-11-13 2002-05-23 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Tiotropiumsalzen und Salzen des Salmeterols
UA75626C2 (en) * 2000-12-28 2006-05-15 Almirall Prodesfarma Ag Quinuclidine derivatives and medicinal compositions containing the same
JP2004530705A (ja) * 2001-05-25 2004-10-07 ベーリンガー インゲルハイム ファルマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 閉塞性気道疾患及びその他の炎症性疾患を治療するためのｐｄｅ４インヒビター及びチオトロピウム又はその誘導体の組み合わせ
DE10130371A1 (de) * 2001-06-23 2003-01-02 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika, Corticosteroiden und Betamimetika
ES2206021B1 (es) * 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
ES2195785B1 (es) 2002-05-16 2005-03-16 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
ES2211315B1 (es) 2002-11-12 2005-10-16 Almirall Prodesfarma, S.A. Nuevos compuestos triciclicos.
ES2211344B1 (es) 2002-12-26 2005-10-01 Almirall Prodesfarma, S.A. Nuevos derivados de piridazin-3(2h)-ona.
PE20040950A1 (es) * 2003-02-14 2005-01-01 Theravance Inc DERIVADOS DE BIFENILO COMO AGONISTAS DE LOS RECEPTORES ADRENERGICOS ß2 Y COMO ANTAGONISTAS DE LOS RECEPTORES MUSCARINICOS
US20060189642A1 (en) * 2003-03-28 2006-08-24 Altana Pharma Ag Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases
EP1610787B1 (fr) * 2003-03-28 2008-01-23 Nycomed GmbH Combinaison synergique comprenant le roflumilast et une substance anticholinergique selectionee parmi le groupe de sels de tiotropium pour le traitement de maladies respiratoires
ES2257152B1 (es) * 2004-05-31 2007-07-01 Laboratorios Almirall S.A. Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.

Also Published As

Publication number Publication date
PT1905451E (pt) 2010-03-31
SI1905451T1 (sl) 2010-05-31
RU2006147269A (ru) 2008-07-20
DE602005012102D1 (de) 2009-02-12
AU2005247106B2 (en) 2010-11-11
IL179685A0 (en) 2007-05-15
IL179690A0 (en) 2007-05-15
CA2569074A1 (fr) 2005-12-08
DK1905451T3 (da) 2010-05-10
ES2336144T3 (es) 2010-04-08
US20130196961A1 (en) 2013-08-01
AU2005247104A1 (en) 2005-12-08
CY1110829T1 (el) 2015-06-10
HRP20100490T1 (hr) 2010-10-31
EP1761279A1 (fr) 2007-03-14
JP2012211183A (ja) 2012-11-01
RU2006146813A (ru) 2008-07-20
EP1891974A1 (fr) 2008-02-27
AU2005247105A1 (en) 2005-12-08
MXPA06013850A (es) 2007-03-02
RS51206B (sr) 2010-12-31
NZ551666A (en) 2010-07-30
MXPA06013846A (es) 2007-03-01
IL179686A0 (en) 2007-05-15
SI1891974T1 (sl) 2010-11-30
AU2005247104B2 (en) 2010-11-11
CA2568568A1 (fr) 2005-12-08
AU2005247105B2 (en) 2010-11-11
WO2005115465A1 (fr) 2005-12-08
ATE419011T1 (de) 2009-01-15
ATE474601T1 (de) 2010-08-15
HRP20090106T3 (en) 2009-03-31
EP1891974B1 (fr) 2010-07-21
PT1765404E (pt) 2009-03-31
ATE454904T1 (de) 2010-01-15
PL1905451T3 (pl) 2010-05-31
IL179690A (en) 2012-10-31
RU2006146673A (ru) 2008-07-20
WO2005115464A1 (fr) 2005-12-08
NZ551670A (en) 2010-07-30
ES2317245T3 (es) 2009-04-16
RU2379033C2 (ru) 2010-01-20
DK1891974T3 (da) 2010-11-08
DE602005018969D1 (de) 2010-03-04
PL1891974T3 (pl) 2010-12-31
HRP20100104T1 (hr) 2010-04-30
CA2568571C (fr) 2012-12-18
US20110224177A1 (en) 2011-09-15
RS51422B (en) 2011-02-28
IL179685A (en) 2012-01-31
EP1905451B1 (fr) 2010-01-13
MXPA06013849A (es) 2007-03-01
CA2568568C (fr) 2012-12-18
DE602005022499D1 (de) 2010-09-02
RS50786B (sr) 2010-08-31
AU2005247106A1 (en) 2005-12-08
RU2404772C2 (ru) 2010-11-27
RU2385156C2 (ru) 2010-03-27
PT1891974E (pt) 2010-09-27
WO2005115463A1 (fr) 2005-12-08
CA2568571A1 (fr) 2005-12-08
CA2569074C (fr) 2012-12-18
EP1905451A1 (fr) 2008-04-02
NZ551669A (en) 2010-07-30
EP2210614A1 (fr) 2010-07-28
EP1765405A1 (fr) 2007-03-28
SI1765404T1 (sl) 2009-04-30

Similar Documents

Publication Publication Date Title
HK1096605A1 (en) Combinations comprising antimuscarinic agents and beta-adrenergic agonists
UA89182C2 (ru) Комбинации, которые содержат антимускариновые агенты и ингибиторы pde4
TR200600314T1 (tr) Antimuskarinik maddeler ve beta-adrenerjik agonistler içeren kombinasyonlar.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20130531